Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
AIDS Behav ; 26(Suppl 1): 165-170, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-35028793

RESUMEN

In 2019, the West Virginia Bureau for Public Health (WV BPH), Cabell-Huntington Health Department (CHHD), and CDC collaborated to respond to an HIV outbreak among people who inject drugs (PWID). CDC, WV BPH, and CHHD formed a cross-agency communications team to establish situational awareness, identify knowledge gaps, and establish key audiences for messages, including the general population, PWID, and clinical and social service providers. The team disseminated up-to-date information about the outbreak, and prioritized messages addressing stigma related to drug use, syringe services programs, and HIV. Messages were continually updated to address the evolving situation and to resonate with local values. Messages were disseminated via advertisements, local news media, and directly to PWID, people experiencing homelessness, and providers. The response supplemented CHHD's assets, including strong relationships and community knowledge, with staff capacity and expertise from state and federal agencies. This collaborative approach is a useful model to address communication needs.


Asunto(s)
Consumidores de Drogas , Infecciones por VIH , Abuso de Sustancias por Vía Intravenosa , Brotes de Enfermedades , Infecciones por VIH/epidemiología , Infecciones por VIH/prevención & control , Humanos , Abuso de Sustancias por Vía Intravenosa/epidemiología , West Virginia/epidemiología
2.
MMWR Morb Mortal Wkly Rep ; 65(29): 745-7, 2016 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-27466758

RESUMEN

Zika virus has been identified as a cause of congenital microcephaly and other serious brain defects (1). CDC issued interim guidance for the prevention of sexual transmission of Zika virus on February 5, 2016, with an initial update on April 1, 2016 (2). The following recommendations apply to all men and women who have traveled to or reside in areas with active Zika virus transmission* and their sex partners. The recommendations in this report replace those previously issued and are now updated to reduce the risk for sexual transmission of Zika virus from both men and women to their sex partners. This guidance defines potential sexual exposure to Zika virus as having had sex with a person who has traveled to or lives in an area with active Zika virus transmission when the sexual contact did not include a barrier to protect against infection. Such barriers include male or female condoms for vaginal or anal sex and other barriers for oral sex.(†) Sexual exposure includes vaginal sex, anal sex, oral sex, or other activities that might expose a sex partner to genital secretions.(§) This guidance will be updated as more information becomes available.


Asunto(s)
Guías como Asunto , Enfermedades Virales de Transmisión Sexual/prevención & control , Infección por el Virus Zika/prevención & control , Centers for Disease Control and Prevention, U.S. , Condones/estadística & datos numéricos , Femenino , Humanos , Masculino , Tamizaje Masivo , Embarazo , Características de la Residencia/estadística & datos numéricos , Abstinencia Sexual , Viaje/estadística & datos numéricos , Estados Unidos , Infección por el Virus Zika/transmisión
3.
MMWR Morb Mortal Wkly Rep ; 63(47): 1113-7, 2014 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-25426654

RESUMEN

In the United States, an estimated 1.2 million persons are living with human immunodeficiency virus (HIV), a serious infection that, if untreated, leads to illness and premature death. Persons living with HIV who use antiretroviral therapy (ART) and achieve very low levels of the virus (suppressed viral load) can have a nearly normal life expectancy and have very low risk for transmitting HIV to others. However, each year in the United States, nearly 50,000 persons become infected with HIV. Each step along the HIV care continuum (HIV diagnosis, prompt and sustained HIV medical care, and ART) is essential for achieving a suppressed viral load.


Asunto(s)
Infecciones por VIH/diagnóstico , Infecciones por VIH/terapia , Adolescente , Adulto , Factores de Edad , Anciano , Terapia Antirretroviral Altamente Activa/estadística & datos numéricos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Estados Unidos , Carga Viral/estadística & datos numéricos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA